Establishing a Successful Pharma-Payer Relationship in 2022

Healthcare payers want more information about new pharma products’ outcomes sooner than ever. Baker Tilly’s Darren Jones talks with PM360 Magazine about how pharmaceutical companies should make a long-term commitment to measuring outcomes as early as possible to provide the real-world evidence payers are seeking and drive commercial success.